Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antiparasitic and antimicrobial agents. The nitroimidazole moiety is known for its biological activity against anaerobic pathogens, making this compound valuable in constructing prodrugs or targeted therapies. Its tert-butyl carbamate (Boc) group allows for controlled amine protection during multi-step organic synthesis, improving selectivity and yield in drug manufacturing processes. Commonly employed in research settings to develop derivatives with enhanced bioavailability and reduced toxicity.